Evidence map›Paper›PMID 38825977›Full record

ArticleHuman brain mapping2024

Principal component analysis as an efficient method for capturing multivariate brain signatures of complex disorders-ENIGMA study in people with bipolar disorders and obesity.

Sean R McWhinney, Jaroslav Hlinka, Eduard Bakstein, Lorielle M F Dietze, Emily L V Corkum, Christoph Abé, Martin Alda, Nina Alexander, Francesco Benedetti, Michael Berk and 81 more

Abstract read
In one paragraph

Article in Human brain mapping, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Differential impact of manic versus depressive episode recurrence on longitudinal gray matter volume changes in bipolar disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. From Stress to Synapse: The Neuronal Atrophy Pathway to Mood Dysregulation.International journal of molecular sciences · 2025
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

91 authors.

Sean R McWhinneyDepartment of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
Jaroslav HlinkaDepartment of Complex Systems, Institute of Computer Science, Czech Academy of Sciences, Prague, Czech Republic.ORCID 0000-0003-1402-1470
Eduard BaksteinNational Institute of Mental Health, Klecany, Czech Republic.
Lorielle M F DietzeDepartment of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
Emily L V CorkumDepartment of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
Christoph AbéDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-1680-8480
Martin AldaDepartment of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
Nina AlexanderDepartment of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
Francesco BenedettiVita-Salute San Raffaele University, Milan, Italy.
Michael BerkInstitute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Victoria, Australia.
Erlend BøenUnit for Psychosomatics/CL Outpatient Clinic for Adults, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Linda M BonnekohInstitute for Translational Psychiatry, University of Münster, Münster, Germany.
Birgitte BoyeUnit for Psychosomatics and C-L Psychiatry for Adults, Oslo University Hospital, Oslo, Norway.
Katharina BroschDepartment of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
Erick J Canales-RodríguezFIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.
Dara M CannonClinical Neuroimaging Laboratory, Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, University of Galway, Galway, Ireland.
Udo DannlowskiInstitute for Translational Psychiatry, University of Münster, Münster, Germany.
Caroline DemroDepartment of Psychiatry & Behavioral Sciences, University of Minnesota, Minneapolis, Minnesota, USA.
Ana Diaz-ZuluagaResearch Group in Psychiatry GIPSI, Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Medellin, Colombia.
Torbjørn ElvsåshagenDepartment of Behavioural Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Lisa T EylerDepartment of Psychiatry, University of California San Diego, La Jolla, California, USA.
Lydia ForteaInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERSAM, Instituto de Salud Carlos III, University of Barcelona, Barcelona, Spain.
Janice M FullertonNeuroscience Research Australia, Randwick, New South Wales, Australia.ORCID 0000-0003-4014-4490
Janik GoltermannInstitute for Translational Psychiatry, University of Münster, Münster, Germany.ORCID 0000-0003-3087-1002
Ian H GotlibDepartment of Psychology, Stanford University, Stanford, California, USA.ORCID 0000-0002-3622-3199
Dominik GrotegerdInstitute for Translational Psychiatry, University of Münster, Münster, Germany.
Bartholomeus HaarmanDepartment of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Tim HahnInstitute for Translational Psychiatry, University of Münster, Münster, Germany.
Fleur M HowellsNeuroscience Institute, University of Cape Town, Cape Town, South Africa.
Hamidreza JamalabadiDepartment of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
Andreas JansenDepartment of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
Tilo KircherDepartment of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
Anna Luisa KlahnInstitute of Neuroscience and Physiology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.
Rayus KuplickiLaureate Institute for Brain Research, Tulsa, Oklahoma, USA.
Elijah LahudDepartment of Psychiatry & Behavioral Sciences, University of Minnesota, Minneapolis, Minnesota, USA.
Mikael LandénInstitute of Neuroscience and Physiology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.
Elisabeth J LeehrInstitute for Translational Psychiatry, University of Münster, Münster, Germany.
Carlos Lopez-JaramilloResearch Group in Psychiatry GIPSI, Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Medellin, Colombia.
Scott MackeyDepartment of Psychiatry, University of Vermont College of Medicine, Burlington, Vermont, USA.
Ulrik MaltUnit for Psychosomatics/CL Outpatient Clinic for Adults, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Fiona MartynClinical Neuroimaging Laboratory, Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, University of Galway, Galway, Ireland.
Elena MazzaVita-Salute San Raffaele University, Milan, Italy.
Colm McDonaldClinical Neuroimaging Laboratory, Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, University of Galway, Galway, Ireland.
Genevieve McPhilemyClinical Neuroimaging Laboratory, Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, University of Galway, Galway, Ireland.
Sandra MeierDepartment of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
Susanne MeinertInstitute for Translational Psychiatry, University of Münster, Münster, Germany.
Elisa MelloniVita-Salute San Raffaele University, Milan, Italy.
Philip B MitchellDiscipline of Psychiatry and Mental Health, School of Clinical Medicine, Faculty of Medicine & Health, University of New South Wales, Sydney, New South Wales, Australia.
Leila NabulsiClinical Neuroimaging Laboratory, Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, University of Galway, Galway, Ireland.
Igor NenadićDepartment of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.ORCID 0000-0002-0749-7473
Robert NitschInstitute for Translational Neuroscience, University of Münster, Münster, Germany.
Nils OpelInstitute for Translational Psychiatry, University of Münster, Münster, Germany.
Roel A OphoffUCLA Center for Neurobehavioral Genetics, Los Angeles, California, USA.
Maria OrtuñoInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Bronwyn J OversNeuroscience Research Australia, Randwick, New South Wales, Australia.
Julian Pineda-ZapataResearch Group, Instituto de Alta Tecnología Médica, Ayudas diagnósticas SURA, Medellin, Colombia.
Edith Pomarol-ClotetFIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.
Joaquim RaduaInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERSAM, Instituto de Salud Carlos III, University of Barcelona, Barcelona, Spain.
Jonathan ReppleInstitute for Translational Psychiatry, University of Münster, Münster, Germany.
Gloria RobertsDiscipline of Psychiatry and Mental Health, School of Clinical Medicine, Faculty of Medicine & Health, University of New South Wales, Sydney, New South Wales, Australia.
Elena Rodriguez-CanoFIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.
Matthew D SacchetMeditation Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Raymond SalvadorFIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.ORCID 0000-0001-5557-1562
Jonathan SavitzLaureate Institute for Brain Research, Tulsa, Oklahoma, USA.
Freda SchefflerNeuroscience Institute, University of Cape Town, Cape Town, South Africa.
Peter R SchofieldNeuroscience Research Australia, Randwick, New South Wales, Australia.
Navid SchürmeyerInstitute for Translational Psychiatry, University of Münster, Münster, Germany.
Chen ShenDepartment of Psychology, University of Minnesota, Minneapolis, Minnesota, USA.
Kang SimWest Region, Institute of Mental Health, Singapore, Singapore.
Scott R SponheimDepartment of Psychiatry & Behavioral Sciences, University of Minnesota, Minneapolis, Minnesota, USA.
Dan J SteinNeuroscience Institute, University of Cape Town, Cape Town, South Africa.
Frederike SteinDepartment of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
Benjamin StraubeDepartment of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
Chao SuoTurner Institute for Brain and Mental Health, School of Psychological Sciences and Monash Biomedical Imaging, Monash University, Melbourne, Victoria, Australia.
Henk TemminghDepartment of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
Lea TeutenbergDepartment of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
Florian Thomas-OdenthalDepartment of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
Sophia I ThomopoulosImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, California, USA.ORCID 0000-0002-0046-4070
Snezana UrosevicDepartment of Psychiatry & Behavioral Sciences, University of Minnesota, Minneapolis, Minnesota, USA.
Paula UsemannDepartment of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
Neeltje E M van HarenDepartment of Child and Adolescent Psychiatry/Psychology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Cristian VargasResearch Group in Psychiatry GIPSI, Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Medellin, Colombia.
Eduard VietaInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERSAM, Instituto de Salud Carlos III, Institute of Neuroscience, University of Barcelona, Hospital Clínic, Barcelona, Spain.
Enric VilajosanaInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Annabel VreekerDepartment of Child and Adolescent Psychiatry/Psychology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Nils R WinterInstitute for Translational Psychiatry, University of Münster, Münster, Germany.
Lakshmi N YathamUniversity of British Columbia, Vancouver, British Columbia, Canada.
Paul M ThompsonImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, California, USA.
Ole A AndreassenInstitute of Clinical Medicine, Norwegian Centre for Mental Disorders Research (NORMENT), University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.ORCID 0000-0002-4461-3568
Christopher R K ChingImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, California, USA.ORCID 0000-0003-2921-3408
Tomas HajekDepartment of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.ORCID 0000-0003-0281-8458

Funding

Training U54EB020403 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2014 to 2018
$10.1M
ENIGMA Bipolar Initiative: A Global Study of Imaging Genomics & Clinical OutcomesR01MH129742 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Christopher Ching, PAUL M THOMPSON · 2022 to 2026
$3.0M
ENIGMA-SD: Understanding Sex Differences in Global Mental Health through ENIGMAR01MH116147 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2018 to 2021
$2.5M
Training in the Multiscale and Multimodal Analysis of Biomarkers in Alzheimer’s DiseaseT32AG058507 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ARTHUR W TOGA · 2018 to 2026
$2.1M
ENIGMA World Aging CenterR56AG058854 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2018 to 2018
$683k
CIHR 106469CIHR 142255NIA NIH HHS R56 AG058854NIA NIH HHS T32 AG058507NIBIB NIH HHS U54 EB020403NIMH NIH HHS R01 MH116147NIMH NIH HHS R01 MH129742Wellcome Trust 103703
6 · The paper itself

Abstract

Multivariate techniques better fit the anatomy of complex neuropsychiatric disorders which are characterized not by alterations in a single region, but rather by variations across distributed brain networks. Here, we used principal component analysis (PCA) to identify patterns of covariance across brain regions and relate them to clinical and demographic variables in a large generalizable dataset of individuals with bipolar disorders and controls. We then compared performance of PCA and clustering on identical sample to identify which methodology was better in capturing links between brain and clinical measures. Using data from the ENIGMA-BD working group, we investigated T1-weighted structural MRI data from 2436 participants with BD and healthy controls, and applied PCA to cortical thickness and surface area measures. We then studied the association of principal components with clinical and demographic variables using mixed regression models. We compared the PCA model with our prior clustering analyses of the same data and also tested it in a replication sample of 327 participants with BD or schizophrenia and healthy controls. The first principal component, which indexed a greater cortical thickness across all 68 cortical regions, was negatively associated with BD, BMI, antipsychotic medications, and age and was positively associated with Li treatment. PCA demonstrated superior goodness of fit to clustering when predicting diagnosis and BMI. Moreover, applying the PCA model to the replication sample yielded significant differences in cortical thickness between healthy controls and individuals with BD or schizophrenia. Cortical thickness in the same widespread regional network as determined by PCA was negatively associated with different clinical and demographic variables, including diagnosis, age, BMI, and treatment with antipsychotic medications or lithium. PCA outperformed clustering and provided an easy-to-use and interpret method to study multivariate associations between brain structure and system-level variables. PRACTITIONER POINTS: In this study of 2770 Individuals, we confirmed that cortical thickness in widespread regional networks as determined by principal component analysis (PCA) was negatively associated with relevant clinical and demographic variables, including diagnosis, age, BMI, and treatment with antipsychotic medications or lithium. Significant associations of many different system-level variables with the same brain network suggest a lack of one-to-one mapping of individual clinical and demographic factors to specific patterns of brain changes. PCA outperformed clustering analysis in the same data set when predicting group or BMI, providing a superior method for studying multivariate associations between brain structure and system-level variables.

Indexed as

Bipolar DisorderMagnetic Resonance ImagingObesityPrincipal Component AnalysisAdultBrainCerebral CortexCluster AnalysisFemaleHumansMaleMiddle AgedSchizophreniaYoung Adultbipolar disorderbody mass indexMRIobesityprincipal component analysispsychiatry

Identifiers

PMID38825977
PMCPMC11144951

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.